Prof. Ravid Straussman

We use cutting-edge, high-throughput technologies to study the different mechanisms that render cancer cells resistant to anti-cancer therapy. Our goal is to advance anti-cancer precision medicine for the creation of better treatment options for cancer patients. Topics of interest include:

• Tumor microenvironment-mediated chemoresistance
• The human microbiome and chemoresistance
• Cell autonomous rewiring as a mechanism for chemoresistance
• The study of drug tolerant persisters
• Study of the timing and mechanisms that drive genetic chemoresistance
• Common models: Melanoma, Breast cancer, lung cancer, pancreatic cancer